STRO

STRO

USD

Sutro Biopharma Inc. Common Stock

$1.100+0.000 (0.000%)

リアルタイム価格

Healthcare
バイオテクノロジー
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$1.100

高値

$1.110

安値

$1.030

出来高

0.07M

企業ファンダメンタルズ

時価総額

92.2M

業種

バイオテクノロジー

United States

取引統計

平均出来高

1.85M

取引所

NGM

通貨

USD

52週レンジ

安値 $0.52現在値 $1.100高値 $5.17

関連ニュース

GlobeNewswire

Sutro Biopharma to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs),

もっと見る
Sutro Biopharma to Participate in Upcoming Investor Conferences
PR Newswire

New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty

Equity Insider News Commentary – Optimism in the field of oncology is on the rise, thanks to the National Institutes of Health's latest annual...

もっと見る
New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty
Analyst Upgrades

HC Wainwright & Co. Reiterates Neutral on Sutro Biopharma, Maintains $2 Price Target

HC Wainwright & Co. analyst Andres Maldonado reiterates Sutro Biopharma with a Neutral and maintains $2 price target.

もっと見る
HC Wainwright & Co. Reiterates Neutral on Sutro Biopharma, Maintains $2 Price Target
GlobeNewswire

Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025

SOUTH SAN FRANCISCO, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs),

もっと見る
Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025

最新情報を入手

価格アラートを設定し、AI分析の更新とリアルタイム市場ニュースを受け取る。